LCB Trademark

Trademark Overview


On Tuesday, December 24, 2024, a trademark application was filed for LCB with the United States Patent and Trademark Office. The USPTO has given the LCB trademark a serial number of 98921336. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 24, 2024. This trademark is owned by LigaChem Biosciences Inc.. The LCB trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; food supplements; vitamin preparations; crude drugs; nutraceuticals for use as a dietary supplement; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for medical use in relation to the treatment of cancer, oncol...
lcb

General Information


Serial Number98921336
Word MarkLCB
Filing DateTuesday, December 24, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, December 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized letters LCB in the color brown.
Goods and ServicesVaccines; food supplements; vitamin preparations; crude drugs; nutraceuticals for use as a dietary supplement; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for medical use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations; cough syrups for pharmaceutical purposes; lozenges for pharmaceutical purposes; cachets for pharmaceutical purposes; chemico-pharmaceutical preparations; antibodies for medical purposes and medical laboratory tests; drugs for medical purposes; medical preparations, namely, antibodies for medical purposes, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, namely, chemical reagents for linking molecules for medical use; pharmaceutical compositions; extracts of medicinal plants, other than essential oils, for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; pharmaceutical products; antibiotics; anti-cancer preparations; mixed vitamin preparations; chemotherapeutics; pharmaceutical preparations for treatment of rare diseases
Indication of Colors claimedThe color(s) brown is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLigaChem Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYuseong-gu, Daejeon 34002
KR

Trademark Events


Event DateEvent Description
Tuesday, December 24, 2024NEW APPLICATION ENTERED